UVADEX: payments to doctors
Payments that named UVADEX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $576K
- Providers
- 201
- Transactions
- 510
- Average per transaction
- $1,129
The per-transaction average — $1,129 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 201 providers the average total is $2,866, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | $293,102 | 50.9% |
| Therakos LLC | $218,082 | 37.9% |
| Mallinckrodt Enterprises LLC | $53,872 | 9.4% |
| Therakos Healthcare LLC | $10,959 | 1.9% |